← Back to Clinical Trials
Recruiting NCT05919758

NCT05919758 Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05919758
Status Recruiting
Phase
Sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Condition Neoplasms
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2023-05-01
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 17 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2023-05-01 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to investigate the beneficial value of complementary surgery for appendiceal neuro-endocrine tumours in children. .

Eligibility Criteria

Inclusion Criteria: * All patients that were treated for an appendiceal NET before the age of 18 years old * Time period: 1990-2020 Exclusion Criteria: * Other appendiceal malignancies/tumours, for example: * goblet cell carcinoma * adenocarcinoma * neuroendocrine carcinoma

Contact & Investigator

Central Contact

Ramon R Gorter, MD PhD

✉ rr.gorter@amsterdamumc.nl

📞 0205669111

Principal Investigator

Ramon R Gorter, MD PhD

STUDY CHAIR

Amsterdam UMC, department of pediatric surgery

Frequently Asked Questions

Who can join the NCT05919758 clinical trial?

This trial is open to participants of all sexes, up to 17 Years, studying Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05919758 currently recruiting?

Yes, NCT05919758 is actively recruiting participants. Contact the research team at rr.gorter@amsterdamumc.nl for enrollment information.

Where is the NCT05919758 trial being conducted?

This trial is being conducted at Amsterdam-Zuidoost, Netherlands.

Who is sponsoring the NCT05919758 clinical trial?

NCT05919758 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The principal investigator is Ramon R Gorter, MD PhD at Amsterdam UMC, department of pediatric surgery. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology